Generic Drugs in India DR BEST Pharmaceuticals

All Generic and Branded Medicines and the rest of the essential medical products on Medkart Pharmacy are sourced directly from reputable manufacturers, ensuring authenticity and compliance with industry standards. The Jan Aushadhi Campaig is a self sustaining business model not dependent on government subsidies or assistance. It is run in a Campaign Mission Mode on the principle of Not for Profits but with Minimal Profits.

How can I inquire about a specific medicine on Medkart Pharmacy?

This competition, along with the lack of R&D and marketing costs, significantly reduces the price of generic medicines. Generic medicines are vital for providing affordable healthcare to millions in India. With initiatives like the Pradhan Mantri Jan Aushadhi Yojana, the country is moving towards a future where quality medicines are available to all, regardless of financial constraints. However, more awareness, policy changes, and efforts to improve public perception are needed to fully unlock the potential of generic medicines in India. Indian manufacturers, with their reverse engineering skills, were the first to market low-cost versions of the life-saving cancer (Imatinib) and HIV drugs (Zidovudine) within a few years of their US launch. The Scheme is being implemented through the Bureau of Pharma PSUs of India (BPPI), under the administrative control of the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India.

The infographic below highlights the sky-high prices of patented drugs in the US vs low-cost Indian generics.

Unlike branded medicines, which spend significantly on advertising and promotion, generic drugs rely less on branding and more on their efficacy, resulting in reduced costs. The government has proposed amendments to the Drugs and Cosmetics Rules to ensure availability of generic drugs at reasonable prices and to promote the use of generic medicines. To ensure high quality, medicines are procured from WHO Good manufacturing practice (GMP), Current Good Manufacturing Practice and CPSUs manufacturers for supplying to Pradhan Mantri Bhartiya Janaushadhi Kendras. Only after being certified by these laboratories, medicines are dispatched to C&F agents, Distributors and JAKs. In contrast to India’s stricter patentability criteria, the U.S. allows the practice of ‘evergreening’ that helps delay generic competition and keeps prices high.

FAQs about Generic Medicines In India

The scheme is being implemented by the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (BPPI), under the administrative control of the Department of Pharmaceuticals and the Ministry of Chemicals and Fertilisers. As of FY23, it covers 1,759 medicines and 280 surgical & consumables in all key therapeutic categories such as anti-infective, anti-allergic, anti-diabetics, cardiovascular, anti-cancers, and gastrointestinal medicines. India should also enter into international partnerships and agreements in the pharmaceutical sector so that we learn from the best and adopt the best protocols and practices.

• Addressing issues related to quality assurance, regulatory enforcement, public awareness, and the perception of generics is essential for improving their acceptance.
• The Vice President said that apart from being the world leader in generic medicines, India should promote Indian systems of Medicine.
• Under the PMBJP Kendras, a medicine is priced on the principle of a maximum of 50% of the average price of the top three branded medicines.
• However, the inactive ingredients (such as fillers, colorants, or preservatives) may vary, but they do not affect the drug’s performance.
• India should also enter into international partnerships and agreements in the pharmaceutical sector so that we learn from the best and adopt the best protocols and practices.
• ConclusionIn conclusion, the PMBJP scheme has been instrumental in making quality generic medicines available and affordable to all sections of society, especially the economically weaker sections in India.

Pradhan Mantri Bhartiya Janaushadhi Pariyojana

With the vision to provide quality generic medicines to all citizens, the government’s Pradhan Mantri Bhartiya Janaushadhi Pariyojana brings this concept to reality. Out of Pocket expenditure on medicines constitutes more than 50% of healthcare expenditure in India. The poor are most affected as branded medicines are expensive and treatments involving the use of such medicines pushes them further into poverty.

Why are generic medicines cheaper?

ConclusionIn conclusion, the PMBJP scheme has been instrumental in making quality generic medicines available and affordable to all sections of society, especially the economically weaker sections in India. The scheme has been successful in increasing the accessibility of medicines to the masses and has helped in reducing healthcare costs for individuals and the government. However, there are still challenges that need to be addressed, such as ensuring the availability and accessibility of medicines in remote areas. The potential of the PMBJP to expand and cover more medicines and medical devices is promising, and it can play a crucial role in achieving the goal of universal health coverage in India. AbstractThis article provides an overview of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) scheme in India. The PMBJP scheme aims to make quality generic medicines available and affordable to all sections of society, especially the economically weaker sections.

TBI Blogs: 5 Reasons Why India Is the ‘Pharmacy’ of the Developing World

• Generic medicines in India must adhere to the same regulatory standards as branded drugs.
• On the other hand, India’s policy and lawmakers have identified generic competition as the strongest and most effective force to reduce drug prices.
• As a leading Jan Aushadhi supplier, we are committed to making high-quality, affordable medicines available to healthcare providers and patients across India.
• Today, India is a main supplier of vaccines to UNICEF and to the Ministries of Health in numerous countries.
• The Vice President of India, Shri M. Venkaiah Naidu has called up on the pharmaceutical industry to work towards making India an International Capital of Generic Medicines.
• The Scheme is being implemented through the Bureau of Pharma PSUs of India (BPPI), under the administrative control of the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India.

It is a common tactic by which the pharmaceutical industry extends their monopoly on drugs beyond the original patent’s 20 years. Long monopoly of a single company in the US  keeps prices high because generic competition is blocked. This problem gets further aggravated as almost 80% of expenditure on health care is borne by the patients themselves.

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

• To ensure high quality, medicines are procured from WHO Good manufacturing practice (GMP), Current Good Manufacturing Practice and CPSUs manufacturers for supplying to Pradhan Mantri Bhartiya Janaushadhi Kendras.
• The National Institute of Pharmaceutical Education and Research (NIPER) imparts quality education in the areas of pharmaceutical sciences.
• The country earned the title of the “pharmacy of the developing world”, providing essential medicines at low prices to countries in Africa, Asia, and Latin America.
• Continued focus on strict regulatory standards is essential to ensure that all generic medicines meet the required quality and safety benchmarks.
• The government should implement policies that incentivize doctors to prescribe generic medicines.
• Generic medicines are vital for providing affordable healthcare to millions in India.
• They help reduce overall healthcare costs, promote health equity, and support government initiatives like the Pradhan Mantri Jan Aushadhi Yojana (PMJAY).
• Under free drug initiatve of National Health Mission (NHM), support is provided for provision of essential generic drugs free of cost in public health facilities.

Indian pharmaceutical companies started exporting generic drugs to developing countries that were grappling with the high cost of healthcare. The country earned the title of the “pharmacy of the developing world”, providing essential medicines at low prices to countries in Africa, Asia, and Latin America. In recent years, generic medicines in India have emerged as a powerful tool in making healthcare more affordable and accessible to millions of people. With rising healthcare costs, the pomalidomide price philippines availability of generic drugs has provided relief to patients by offering low-cost alternatives without compromising on quality. This article explores the significance of generic medicines in India, their role in the healthcare system, and why they are key to reducing out-of-pocket expenditure on healthcare. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a campaign launched by the Department of Pharmaceuticals to provide quality medicines at affordable prices to the masses.

Medicines for BP Problems

Yes, Medkart Pharmacy offers a diverse range of over-the-counter products to meet common health needs. We at Medkart Pharmacy dream of making sure that everyone is truly aware of Generic Medicines. You can also buy essential medical products, branded or generic medicines online from medkart official website. Increasing the number of Jan Aushadhi Kendras across India, especially in rural areas, can ensure the availability of generic medicines to even the most underserved populations. As India continues to address its healthcare challenges, the role of generic medicines will remain vital in ensuring that all individuals have access to the medications they need for maintaining good health. Despite these changes, Indian pharmaceutical companies continued to thrive by focusing on producing generics for medicines whose patents had expired and exporting them worldwide.

Drug Price List: Generics and Matching Brands

Pradhan Mantri Bhartiya Janaushadhi Kendra scheme ensures quality generic medicines available at affordable prices to all citizens. Under the scheme, dedicated outlets known as Janaushadhi Kendras are opened to provide generic medicines at affordable prices. By providing affordable medication options, generic medicines ensure that low-income individuals and underserved populations have access to necessary treatments, reducing healthcare disparities across the country. Generic medicines are produced after the patent on a branded drug expires, allowing multiple manufacturers to make the same drug.

• Additionally, the scheme has extended coverage to senior citizens aged 70 and above.
• Long monopoly of a single company in the US  keeps prices high because generic competition is blocked.
• The Jan Aushadhi initiative will make available quality drugs at affordable prices through dedicated stores selling generic medicines which are available at lesser prices but are equivalent in quality and efficacy as expensive branded drugs.
• Generic medicines can only be produced after the patent on the brand-name drug has expired.
• As of December 2023, the government has already established 10,006, with 206 medicines and 13 surgical equipment have been newly added this year in Jan Aushadhi stores in the country.
• Generic drugs are tested rigorously to ensure they meet the same safety and efficacy standards as brand-name drugs.

Medkart Pharmacy offers informational content on various health topics, promoting awareness and well-being among our customers. New molecules and new drugs will have to be discovered and treatment protocols will have to be continuously upgraded and updated. The National Institute of Pharmaceutical Education and Research (NIPER) imparts quality education in the areas of pharmaceutical sciences. Healthcare is the fifth-largest employer among all sectors, both in terms of direct and indirect employment. Given the significance of highly educated and specialized scientists in the sector, skill development is crucial.

Providing Affordable, High-quality Generic Meds Globally

Developing countries across the world face several challenges, key among which is providing their people with affordable medicines of high-quality. You can purchase generic medicines at Jan Aushadhi Kendras (government-run stores) and most pharmacies across India. These stores offer a variety of affordable generic alternatives for common medicines.

This leads to lower costs because generic manufacturers do not incur the high expenses of research and marketing. As of July 2024, ~13,113 Pradhan Mantri Bhartiya Janaushadhi Pariyojana Kendras were operational in India. Under the PMBJP Kendras, a medicine is priced on the principle of a maximum of 50% of the average price of the top three branded medicines. Therefore, the cost of Jan Aushadhi medicines is cheaper by ~50% and in some cases, by 80-90% of the market price for branded medicines. Rural health programmes, lifesaving drugs and preventive vaccines should also receive attention from policy makers and Pharma companies alike.

In order to ensure quality of the products, PMBI procures medicines only from World Health Organization – Good Manufacturing Practices (WHO-GMP) certified suppliers. Apart from this, each batch of drug is tested at laboratories accredited by ‘National Accreditation Board for Testing and Calibration Laboratories (NABL). Only after passing the quality tests, the medicines are dispatched to PMBJP Kendras. The government has also launched a mobile application ‘Janaushadhi Sugam’ that provides information to public about location of kendras, help them search Janaushadhi medicines and compare the maximum retail price of Generic vs. Branded medicines, etc.

The Role of Generic Medicines in India’s Healthcare System

Further, Clause 1.5 of Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 prescribes that every physcian should prescribe drugs with generic names legibly and preferably in capital letters. Additionally, the erstwhile Medical Council of India (MCI) had issued Circulars vide which all the Registered Medical Practitioners have been directed to comply with the aforesaid provisions. You can trust Indiangenericprice for reliable access to specialized medications that are affordable and delivered worldwide.

Generic medicines play a crucial role in promoting health equity by ensuring that medications are accessible to all segments of the population, regardless of socioeconomic status. This is particularly important in a diverse country like India, where disparities in access to healthcare can be significant. The production of affordable generics helped address critical healthcare needs in India, particularly in treating infectious diseases like tuberculosis and malaria, which were prevalent across the country. Pharma companies should go above and beyond their CSR mandates to provide life saving and other essential drugs to those who cannot afford them. Quality medicines at affordable prices are now available to the poor and disadvantaged through the “Pradhan Mantri Bhartiya Jan aushadhi Kendras”.